COMPASS Pathways PLC ADR (CMPS) Social Stream



COMPASS Pathways PLC ADR (CMPS): $17.61

0.65 (+3.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About CMPS

$MYCOF When the market finally realizes what they've been sleeping on... 🚀

Exclusive Access to a Full cGMP Certified Pharmaceutical Manufacturing Facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada.

Seven Patent Pending Applications That Represent Thousands of Inventions with multiple layers of protection on the company’s proprietary medical development pipeline.

Numerous Clinical Trials are currently underway, including a Phase 2A clinical trial on PTSD in Veterans, EMS, and Front Line Workers, a First-of-its-Kind Microdose Study, and Preclinical Animal Work for a Late-State Addiction Study aiming at a Mechanistic Understanding of Psilocybin.

$CYBN $ATAI $MNMD $CMPS << These are all awesome and I hold positions in each.
BleedingHeartCapitalist, published August 13, 2021

What Else are CMPS Traders Talking About?


Other tickers frequently mentioned alongside CMPS are ATAI and MNMD.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.365 seconds.